新日本製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 化学 | 4931/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/12/04 | 日証協 | 296,552株 | +39% | 114,100株 | +67.29% | 194,650株 | +28.19% | 365,310株 | +210.9% |
2020/11/27 | 日証協 | 213,352株 | -1.82% | 68,204株 | +405.21% | 151,840株 | +10.64% | 117,500株 | +259.32% |
2020/11/20 | 日証協 | 217,317株 | -12.17% | 13,500株 | -91.84% | 137,241株 | -3.45% | 32,701株 | -59.58% |
2020/11/13 | 日証協 | 247,417株 | +0.08% | 165,417株 | +176% | 142,140株 | -10.29% | 80,900株 | +405.62% |
2020/11/06 | 日証協 | 247,217株 | +5.85% | 59,934株 | +93.64% | 158,440株 | -1.18% | 16,000株 | -6.54% |
2020/10/30 | 日証協 | 233,552株 | +3.5% | 30,952株 | -32.64% | 160,340株 | +2.7% | 17,120株 | -38.09% |
2020/10/23 | 日証協 | 225,652株 | +3.3% | 45,952株 | +20.76% | 156,120株 | -1.58% | 27,655株 | +197.05% |
2020/10/16 | 日証協 | 218,452株 | +18.66% | 38,052株 | -50.87% | 158,620株 | +1.55% | 9,310株 | -81.28% |
2020/10/09 | 日証協 | 184,100株 | +40.11% | 77,452株 | +297.19% | 156,200株 | -2.92% | 49,720株 | -46.63% |
2020/10/02 | 日証協 | 131,400株 | -13.21% | 19,500株 | -51.25% | 160,891株 | -3.83% | 93,164株 | +16.16% |
2020/09/25 | 日証協 | 151,400株 | -21.39% | 40,000株 | +6.95% | 167,291株 | +5.95% | 80,200株 | +437.89% |
2020/09/18 | 日証協 | 192,600株 | +0.31% | 37,400株 | -10.74% | 157,891株 | +0.26% | 14,910株 | +101.43% |
2020/09/11 | 日証協 | 192,000株 | +0.37% | 41,900株 | -63.66% | 157,481株 | -20.17% | 7,402株 | -94.79% |
2020/09/04 | 日証協 | 191,300株 | -19.59% | 115,300株 | +234.2% | 197,259株 | +16.41% | 142,130株 | +131.4% |
2020/08/28 | 日証協 | 237,900株 | -6.85% | 34,500株 | -38.94% | 169,451株 | +5.89% | 61,423株 | +218.02% |
2020/08/21 | 日証協 | 255,400株 | -4.17% | 56,500株 | -42.76% | 160,024株 | -6.1% | 19,314株 | -15.7% |
2020/08/14 | 日証協 | 266,500株 | +7.98% | 98,700株 | +141.91% | 170,423株 | +0.48% | 22,910株 | -10.89% |
2020/08/07 | 日証協 | 246,800株 | +3.96% | 40,800株 | +110.31% | 169,614株 | +4.89% | 25,711株 | +82.35% |
2020/07/22 | 日証協 | 245,400株 | -5.14% | 56,600株 | -71.03% | 165,203株 | -16.18% | 15,100株 | -77.4% |
※株式分割は考慮していませんのでご注意ください。
Page Top